Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 11/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.58 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10044916 | 1.00 | CYP19A1 (1.00) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL28533317 | 0.98 | CYP19A1 (0.97) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL16206208 | 0.91 | CYP19A1 (0.82) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL2641384 | 0.88 | CYP19A1 (1.00) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL2194279 | 0.88 | CYP19A1 (0.77) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL15795903 | 0.85 | CYP19A1 (0.74) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL15796292 | 0.84 | CYP19A1 (0.72) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL15836589 | 0.84 | CYP19A1 (0.72) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL30657567 | 0.84 | CYP19A1 (0.72) | CYP19A1HDAC1HSP90AB1HRH4MAOA | |
| SCHEMBL28220729 | 0.82 | CYP19A1 (0.70) | CYP19A1HDAC1HSP90AB1HRH4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101704793-A | 5-alkenyl-1, 4-disubstituted-1, 2, 3-triazole compound, preparation method and application thereof | UNIV SOUTH CHINA TECH | 2010-05-12 | — | — | CN | claimed |
| CN-112275322-B | Preparation method and application of supported CNTs @ NHC-Cu catalytic material | 中国科学院兰州化学物理研究所 | 2022-01-25 | — | — | CN | disclosed |
| CN-112275322-A | Preparation method and application of supported CNTs @ NHC-Cu catalytic material | 中国科学院兰州化学物理研究所 | 2021-01-29 | — | — | CN | disclosed |
| US-9375705-B2 | Heterogeneous copper nanocatalyst and manufacturing methods thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2016-06-28 | — | — | US | disclosed |
| US-8877676-B2 | Heterogeneous copper nanocatalyst and manufacturing methods thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2014-11-04 | — | — | US | disclosed |
| US-20140302984-A1 | HETEROGENEOUS COPPER NANOCATALYST AND MANUFACTURING METHODS THEREOF | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2014-10-09 | — | — | US | disclosed |
| CN-101704793-B | 5-alkenylated-1, 4-disubstituted-1, 2, 3-triazole compound and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2012-05-09 | — | — | CN | disclosed |
| US-20110172417-A1 | Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2011-07-14 | — | — | US | disclosed |
| CN-101704793-A | 5-alkenyl-1, 4-disubstituted-1, 2, 3-triazole compound, preparation method and application thereof | UNIV SOUTH CHINA TECH | 2010-05-12 | — | — | CN | disclosed |
| WO-2010005127-A2 | HETEROGENEOUS COPPER NANOCATALYST AND MANUFACTURING METHODS THEREOF | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2010-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172417-A1 | Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof | AOC3, AOC2, USP13 | CYP19A1 2195/4885HDAC1 3432/4885HSP90AB1 3863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.